---
title: "This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299893372.md"
description: "Top Wall Street analysts initiated bullish coverage on five stocks: HCA Healthcare (Outperform, $495 PT), Guardian Pharmacy Services (Overweight, $52 PT), Toro Co (Outperform, $120 PT), Marvell Technology (Buy, $270 PT), and Pulse Biosciences (Buy, $70 PT). These initiations by BMO, Keybanc, Oppenheimer, Seaport Global, and BTIG set positive outlooks for the respective companies."
datetime: "2026-09-23T11:49:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299893372.md)
  - [en](https://longbridge.com/en/news/299893372.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299893372.md)
generator: "portal-rs"
---

# This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   BMO Capital analyst Sean Dodge initiated coverage on **HCA Healthcare Inc** (NYSE:HCA) with an Outperform rating and announced a price target of $495. HCA Healthcare closed at $438.12 on Tuesday. See how other analysts view this stock.
-   Keybanc analyst Zach Haggerty initiated coverage on **Guardian Pharmacy Services Inc** (NYSE:GRDN) with an Overweight rating and announced a price target of $52. Guardian Pharmacy shares closed at $44.67 on Tuesday. See how other analysts view this stock.
-   Oppenheimer analyst Kristen Owen initiated coverage on **Toro Co** (NYSE:TTC) with an Outperform rating and announced a price target of $120. Toro closed at $94.52 on Tuesday. See how other analysts view this stock.
-   Seaport Global analyst Jay Goldberg initiated coverage on **Marvell Technology Inc** (NASDAQ:MRVL) with a Buy rating and announced a price target of $270. Marvell Technology shares closed at $262.36 on Tuesday. See how other analysts view this stock.
-   BTIG analyst Marie Thibault initiated coverage on **Pulse Biosciences Inc** (NASDAQ:PLSE) with a Buy rating and announced a price target of $70. Pulse Biosciences closed at $52.69 on Tuesday. See how other analysts view this stock.

Considering buying HCA stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [TTC.US](https://longbridge.com/en/quote/TTC.US.md)
- [MRVL.US](https://longbridge.com/en/quote/MRVL.US.md)
- [GRDN.US](https://longbridge.com/en/quote/GRDN.US.md)
- [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md)
- [HCA.US](https://longbridge.com/en/quote/HCA.US.md)
- [MVLL.US](https://longbridge.com/en/quote/MVLL.US.md)
- [MRVU.US](https://longbridge.com/en/quote/MRVU.US.md)

## Related News & Research

- [Marvell Just Unveiled a 2nm Breakthrough for AI Data Centers](https://longbridge.com/en/news/300048510.md)
- [Brainhole Technology Exits Marvell Stake in Discloseable Share Disposal](https://longbridge.com/en/news/300027864.md)
- [Is Pulse Biosciences (PLSE) Fully Valued As Its Thyroid Trial Reaches 100 Patients?](https://longbridge.com/en/news/299817418.md)
- [Why Marvell stock rallied today](https://longbridge.com/en/news/299678475.md)
- [AT&S expands Kulim plant, adding IC substrate capacity for AI infrastructure demand](https://longbridge.com/en/news/299727421.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**